Strategy-Launch and Pre-Launch Clinical Trials

Previous Page 1 of 20 Next >

Search returned 195 items.

sort by: Title | Author | Publication | Date

Prostate Cancer: FDA Approves Drug for Patients with Advanced Prostate Cancer

These agents slow the growth and progression of prostate cancer by suppressing testosterone, which plays an important role in the continued growth of prostate cancer.

Date: 12/29/2008 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01935.html

Gastrointestinal Cancer: FDA Approves Gleevec to Prevent Recurrence of Rare Gastrointestinal Cancer

GIST is a fairly rare form of cancer that originates in cells found in the wall of the GI tract...

Date: 12/19/2008 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01931.html

Bone Marrow Transplants: FDA Approves Drug that Boosts Stem Cell Yield for Bone Marrow Transplants

Mozobil is intended to be used in combination with the growth factor granulocyte-colony stimulating factor (G-CSF), for treatment of adults with multiple myeloma or non-Hodgkin’s lymphomas...

Date: 12/18/2008 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01929.html

Cleviprex IV therapy approved by FDA

Cleviprex is a dihydropyridine calcium channel blocker...

Date: 12/12/2008 , Publication: Drug Topics , Author: By: Julio Fernandez, Pharm.D.

http://drugtopics.modernmedicine.com/drugtopics/Treatment+Areas/Cleviprex-IV-th

New antihypertensive drugs' place in therapy not yet known

The niches that aliskiren and nebivolol, two newly approved therapies for hypertension, will occupy in the therapeutic armamentarium for hypertension...

Date: 12/12/2008 , Publication: Drug Topics , Author: Drug Topics

http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Conference+News

Europe Reviews Balance of Interests

Animal use in clinical trials comes into question as Europe debates an update of current rules.

Date: 11/28/2008 , Publication: Applied Clinical Trials , Author: By: Peter O'Donnell

http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/Regulat

Skin Structure Infections: Ceftobiprole: Monitoring Issues Cause Drug Delay

...a Complete Response Letter for ceftobiprole for the treatment of complicated skin and skin structure infections including diabetic foot infections.

Date: 11/28/2008 , Publication: Applied Clinical Trials , Author: Company News Release

http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/News/Mo

Ferumoxytol May Get FDA Decision by Year's End

resubmission for its iron-deficiency anemia treatment ferumoxytol as a complete Class 1 response and plans to make...

Date: 11/27/2008 , Publication: FDAnews.com , Author: FDAnews Drug Daily Bulletin

http://www.fdanews.com/newsletter/article?articleId=112628&issueId=12187

Patient-led drug trials defy medical bureaucracy

ALS sufferers share health details in hopes of finding their own treatment

Date: 11/26/2008 , Publication: MSNBC , Author: AP

http://www.msnbc.msn.com/id/27929349/

EU Report Slams Drug Industry Practices

BRUSSELS/LONDON (Reuters) - A European report on competition in the pharmaceuticals sector will criticise drug companies for the way they prolong drug patents...

Date: 11/25/2008 , Publication: TherapeuticsDaily.com , Author: By Darren Ennis and Ben Hirschler

http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1868071&contentT

Previous Page 1 of 20 Next >

Search returned 195 items.